PMID: 8471446Apr 1, 1993Paper

Advanced breast cancer: use of resources and cost implications

British Journal of Cancer
M A RichardsR D Rubens

Abstract

Little information is currently available on the use of hospital resources and the resulting costs of treating any advanced cancer. Such data may be useful for planning purposes and for calculating the cost effectiveness of measures designed to reduce the incidence of advanced disease (such as the National Breast Screening Programme). A retrospective analysis of the medical records of 50 patients with advanced breast cancer who attended the Guy's Hospital Oncology Unit and who died between October 1988 and December 1990 has therefore been undertaken. For each patient, the duration of in-patient stays and principal indications for admissions were recorded, together with the number of out-patient attendances. Details of endocrine treatment, chemotherapy and radiotherapy were abstracted as were all radiological and laboratory investigations. Costs for each of these activities were calculated. The median duration of advanced disease was 17 months (mean 27 months; range 7 days-12 years). The mean cost of treatment per patients was calculated to be 7,620 pounds (range 317 pounds-27,860 pounds). Mean duration of in-patient stay was 32 days (0-133) and this accounted for 56% of total costs. The large majority (> 80%) of the time spent ...Continue Reading

Citations

Aug 1, 2002·Drugs & Aging·Michael S SimonMiron Stano
Jan 1, 1996·Acta Oncologica·R E ColemanJ J Vinholes
Jun 24, 2004·Expert Opinion on Pharmacotherapy·Richard P C VineyHitendra R H Patel
Dec 4, 2003·British Journal of Cancer·J E BrownR E Coleman
Dec 1, 2003·Expert Review of Pharmacoeconomics & Outcomes Research·Amin M AlousiMichael S Simon
May 25, 2011·BMC Cancer·Misericordia CarlesMontserrat Rue
Aug 13, 1999·Breast Cancer Research and Treatment·S A McLachlanI F Tannock
Dec 22, 2004·International Journal of Technology Assessment in Health Care·Karin FlobbeJos M A van Engelshoven
Apr 5, 2005·Pharmazie in unserer Zeit·Eva Susanne Dietrich
Jun 10, 2004·British Journal of Cancer·E Remák, L Brazil
Jun 5, 1998·International Journal of Technology Assessment in Health Care·J L WolstenholmeD K Whynes
Jul 2, 2003·Drugs & Aging·Nicola Lucio LiberatoGiovanni Barosi
Mar 17, 2001·Journal of Advanced Nursing·S PearceW Stevens
May 21, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G BocciM Del Tacca

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Intensive Care : International Journal of Critical & Coronary Care Medicine
A M ShiellJ Spiby
Dental Traumatology : Official Publication of International Association for Dental Traumatology
Ferranti S L Wong, Konstantina Kolokotsa
© 2021 Meta ULC. All rights reserved